Primary aldosteronism: a common cause of resistant hypertension.
作者信息
Kline Gregory A, Prebtani Ally P H, Leung Alexander A, Schiffrin Ernesto L
机构信息
Department of Endocrinology (Kline, Leung), University of Calgary, Calgary, Alta.; Department of Internal Medicine, Endocrinology and Metabolism (Prebtani), McMaster University, Hamilton, Ont.; Department of Medicine (Schiffrin), Jewish General Hospital and Lady Davis Research Institute, McGill University, Montréal, Que.
出版信息
CMAJ. 2017 Jun 5;189(22):E773-E778. doi: 10.1503/cmaj.161486.
Abstract
摘要
相似文献
1
Primary aldosteronism: a common cause of resistant hypertension.原发性醛固酮增多症：难治性高血压的常见病因。
CMAJ. 2017 Jun 5;189(22):E773-E778. doi: 10.1503/cmaj.161486.
2
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.原发性醛固酮增多症，通过醛固酮与肾素比值诊断，是高血压的常见病因。
Clin Endocrinol (Oxf). 2003 Oct;59(4):427-30. doi: 10.1046/j.1365-2265.2003.01841.x.
3
Primary aldosteronism: revival of a syndrome.
J Hypertens. 2001 Mar;19(3):363-6. doi: 10.1097/00004872-200103000-00002.
4
[Primary aldosteronism].[原发性醛固酮增多症]
Rev Med Chil. 2008 Jul;136(7):905-14. Epub 2008 Sep 4.
5
The current epidemic of primary aldosteronism: causes and consequences.原发性醛固酮增多症的当前流行情况：病因与后果
J Hypertens. 2004 Oct;22(10):2039-40; author reply 2040. doi: 10.1097/00004872-200410000-00032.
6
The current epidemic of primary aldosteronism: causes and consequences.原发性醛固酮增多症的当前流行情况：病因与后果
J Hypertens. 2004 Oct;22(10):2040-2. doi: 10.1097/00004872-200410000-00034.
7
Primary aldosteronism.原发性醛固酮增多症
Urol Clin North Am. 1977 Jun;4(2):227-37.
8
Cautions over the current epidemic of primary aldosteronism.对当前原发性醛固酮增多症流行情况的警示。
Lancet. 2001 Mar 24;357(9260):953-4. doi: 10.1016/S0140-6736(00)04223-9.
9
Primary aldosteronism: emerging trends.原发性醛固酮增多症：新趋势。
Trends Endocrinol Metab. 2013 Sep;24(9):421-30. doi: 10.1016/j.tem.2013.05.003. Epub 2013 Jun 21.
10
Primary aldosteronism: management issues.原发性醛固酮增多症：管理问题
Ann N Y Acad Sci. 2002 Sep;970:61-76. doi: 10.1111/j.1749-6632.2002.tb04413.x.
引用本文的文献
1
Evaluation of Predictive Risk Factors of Persistent Hypertension in Hyperaldosteronism After Surgery.原发性醛固酮增多症术后持续性高血压的预测危险因素评估
Int J Endocrinol Metab. 2025 Apr 30;23(2):e156728. doi: 10.5812/ijem-156728.
2
Total or partial adrenalectomy for aldosterone-producing adenoma: can Ga-Pentixafor PET/CT predict surgical outcomes?醛固酮瘤的全肾上腺切除术或部分肾上腺切除术：镓-喷替沙福PET/CT能否预测手术结果？
Eur J Nucl Med Mol Imaging. 2025 Apr 4. doi: 10.1007/s00259-025-07244-9.
3
Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess.肾上腺静脉采血与影像学检查结果不一致：单侧皮质醇过多的作用。
Eur J Endocrinol. 2025 Mar 3;192(3):191-201. doi: 10.1093/ejendo/lvaf019.
4
Clinical practice guideline for the management of hypertension in China.《中国高血压防治临床指南》
Chin Med J (Engl). 2024 Dec 20;137(24):2907-2952. doi: 10.1097/CM9.0000000000003431. Epub 2024 Dec 9.
5
Cutoff Values of Aldosterone and the Aldosterone-Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study.醛固酮及醛固酮-肾素比值预测顽固性高血压患者原发性醛固酮增多症的临界值：一项真实世界研究
J Cardiovasc Dev Dis. 2024 Sep 27;11(10):299. doi: 10.3390/jcdd11100299.
6
Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review.原发性醛固酮增多症中肾上腺切除术与药物治疗的心血管及全因死亡率结局：一项综合性综述
Int J Surg. 2024 Nov 1;110(11):7367-7380. doi: 10.1097/JS9.0000000000002048.
7
Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout.高血压患者血浆醛固酮浓度升高：对高尿酸血症和痛风的双重影响。
Front Endocrinol (Lausanne). 2024 Jul 30;15:1424207. doi: 10.3389/fendo.2024.1424207. eCollection 2024.
8
Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk.中老年高血压患者血浆醛固酮浓度与骨密度的相关性：对骨质疏松症和未来骨折风险的潜在影响。
Front Endocrinol (Lausanne). 2024 May 14;15:1373862. doi: 10.3389/fendo.2024.1373862. eCollection 2024.
9
Commensal microbiota regulate aldosterone.共生微生物群调节醛固酮。
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1032-F1038. doi: 10.1152/ajprenal.00051.2024. Epub 2024 Apr 18.
10
Adrenal Vein Sampling in the Management of Primary Aldosteronism: The Added Value of Intraprocedural Cortisol Assessment.肾上腺静脉采血在原发性醛固酮增多症管理中的应用：术中皮质醇评估的附加价值
Int J Endocrinol. 2023 Dec 21;2023:5563881. doi: 10.1155/2023/5563881. eCollection 2023.
本文引用的文献
1
Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.原发性醛固酮增多症肾上腺切除术后高血压缓解患者的比例：一项系统评价和荟萃分析
J Clin Hypertens (Greenwich). 2016 Dec;18(12):1205-1212. doi: 10.1111/jch.12916. Epub 2016 Oct 19.
2
Effects of Treating Primary Aldosteronism on Renal Function.原发性醛固酮增多症的治疗对肾功能的影响。
J Clin Hypertens (Greenwich). 2017 Mar;19(3):290-295. doi: 10.1111/jch.12914. Epub 2016 Sep 23.
3
Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.饮食限钠会增加误诊轻度原发性醛固酮增多症病例的风险。
J Clin Endocrinol Metab. 2016 Nov;101(11):3989-3996. doi: 10.1210/jc.2016-1963. Epub 2016 Jul 18.
4
Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.研究原发性醛固酮增多症的异质性和患病率估计：系统评价和荟萃回归分析。
J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35. doi: 10.1210/jc.2016-1472. Epub 2016 May 12.
5
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.加拿大高血压协会《2016年加拿大高血压教育计划血压测量、诊断、风险评估、预防及治疗指南》
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
6
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.原发性醛固酮增多症的管理：病例检出、诊断和治疗：内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2016 May;101(5):1889-916. doi: 10.1210/jc.2015-4061. Epub 2016 Mar 2.
7
Epidemiology of Hypertension in Canada: An Update.加拿大高血压流行病学：更新。
Can J Cardiol. 2016 May;32(5):687-94. doi: 10.1016/j.cjca.2015.07.734. Epub 2015 Aug 15.
8
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.螺内酯与安慰剂、比索洛尔及多沙唑嗪对比以确定难治性高血压的最佳治疗方案（PATHWAY-2）：一项随机、双盲、交叉试验
Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20.
9
Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.醛固酮损害血管平滑肌功能：从临床到基础研究
J Clin Endocrinol Metab. 2015 Nov;100(11):4339-47. doi: 10.1210/jc.2015-2752. Epub 2015 Sep 24.
10
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.德国 Conn 登记处原发性醛固酮增多症患者中糖尿病和代谢综合征的患病率增加。
Eur J Endocrinol. 2015 Nov;173(5):665-75. doi: 10.1530/EJE-15-0450. Epub 2015 Aug 26.
Zotero 插件